Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19

The vast majority of COVID-19 patients experience a mild disease. However, a minority suffers from critical disease with substantial morbidity and mortality. To identify individuals at risk of critical COVID-19, the relevance of a seroreactivity against seasonal human coronaviruses was analyzed. We...

全面介绍

Saved in:

书目详细资料
Main Authors:	Martin Dugas, Tanja Grote-Westrick, Uta Merle, Michaëla Fontenay, Andreas E. Kremer, Frank Hanses, Richard Vollenberg, Eva U. Lorentzen, Shilpa Tiwari‐Heckler, Jérôme Duchemin, Syrine Ellouze, Marcel Vetter, Julia Fürst, Philipp Schuster, Tobias Brix, Claudia M. Denkinger, Carsten Müller‐Tidow, Hartmut Schmidt, Phil‐Robin Tepasse, Joachim Kühn
格式:	Artigo
语言:	英语
出版:	2021
在线阅读:	https://doi.org/10.1016/j.jcv.2021.104847
标签:	添加标签没有标签, 成为第一个标记此记录!

因特网

https://doi.org/10.1016/j.jcv.2021.104847

Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19

因特网

相似书籍